Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Preferred Shares: 2017-2024

Historic Preferred Shares for Fortress Biotech (FBIO) over the last 8 years, with Dec 2024 value amounting to $3,000.

  • Fortress Biotech's Preferred Shares changed negligibly% to $3,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3,000 for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Fortress Biotech's Preferred Shares is $3,000, which was down 0.00% from $3,000 recorded in FY2023.
  • Over the past 5 years, Fortress Biotech's Preferred Shares peaked at $3,000 during FY2020, and registered a low of $3,000 during FY2020.
  • For the 3-year period, Fortress Biotech's Preferred Shares averaged around $3,000, with its median value being $3,000 (2024).
  • Data for Fortress Biotech's Preferred Shares shows a peak YoY skyrocketed of 200.00% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Fortress Biotech's Preferred Shares stood at $3,000 in 2020, then remained steady at $3,000 in 2021, then remained steady at $3,000 in 2022, then remained steady at $3,000 in 2023, then remained steady at $3,000 in 2024.